NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free NAOV Stock Alerts $0.77 +0.02 (+2.67%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.76▼$0.7850-Day Range$0.75▼$1.2852-Week Range$0.70▼$4.34Volume7,817 shsAverage Volume83,099 shsMarket Capitalization$2.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get NanoVibronix alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About NanoVibronix Stock (NASDAQ:NAOV)NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More NAOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NAOV Stock News HeadlinesApril 20, 2024 | americanbankingnews.comNanoVibronix (NASDAQ:NAOV) Share Price Passes Below Fifty Day Moving Average of $0.95April 10, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023April 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.April 9, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMarch 28, 2024 | finance.yahoo.comNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldFebruary 23, 2024 | benzinga.comMagnolia Oil & Gas Stock (NYSE:MGY), Quotes and News SummaryFebruary 2, 2024 | uk.finance.yahoo.comNanoVibronix, Inc. (NAOV)January 7, 2024 | morningstar.comNanoVibronix Inc NAOVApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.December 6, 2023 | finance.yahoo.comNanoVibronix Featured in Your Bladder Health MagazineDecember 4, 2023 | finance.yahoo.comNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNovember 28, 2023 | markets.businessinsider.comNanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of MichiganNovember 28, 2023 | finance.yahoo.comNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNovember 7, 2023 | finance.yahoo.comNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1September 27, 2023 | finanznachrichten.deNanoVibronix, Inc.: NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug TariffSeptember 27, 2023 | finance.yahoo.comNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffSeptember 6, 2023 | finance.yahoo.comNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingAugust 31, 2023 | seekingalpha.comAMC, MMLP and ARAV among mid-day moversAugust 30, 2023 | msn.comNanoVibronix to raise $5M through private placementAugust 30, 2023 | finance.yahoo.comWhy Is NanoVibronix Stock Trading Higher Today?August 30, 2023 | finance.yahoo.comNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesAugust 30, 2023 | investorplace.comWhy Is NanoVibronix (NAOV) Up 153% Today?August 30, 2023 | finance.yahoo.comNanoVibronix Cites Positive Results from Independent Testing of UroShieldAugust 29, 2023 | finance.yahoo.comNanoVibronix Responds to CMS’ Determination for PainShieldAugust 28, 2023 | finance.yahoo.comNanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffAugust 23, 2023 | markets.businessinsider.comNanoVibronix Extends Distribution Deal With UPPI For PainShield, PainShield PlusAugust 23, 2023 | finance.yahoo.comNanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield PlusSee More Headlines Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/08/2024Today4/25/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-162.55% Pretax Margin-161.28% Return on Equity-123.23% Return on Assets-65.46% Debt Debt-to-Equity RatioN/A Current Ratio2.64 Quick Ratio1.53 Sales & Book Value Annual Sales$2.28 million Price / Sales0.93 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.39Miscellaneous Outstanding Shares2,780,000Free Float2,684,000Market Cap$2.11 million OptionableNot Optionable Beta1.25 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Brian M. Murphy (Age 67)CEO & Director Comp: $342.5kMr. Stephen R. Brown CPA (Age 68)Chief Financial Officer Comp: $276.5kDr. Harold Jacob M.D. (Age 70)Chief Medical Officer & Director Mr. Amir RippelVice President of MarketingMs. Lindsey HarrisonVice President of SalesKey CompetitorsBone BiologicsNASDAQ:BBLGSientraNASDAQ:SIENQPredictive OncologyNASDAQ:POAIHeart Test LaboratoriesNASDAQ:HSCSAclarionNASDAQ:ACONView All Competitors NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed in 2024? NanoVibronix's stock was trading at $1.15 at the start of the year. Since then, NAOV stock has decreased by 33.2% and is now trading at $0.7680. View the best growth stocks for 2024 here. Are investors shorting NanoVibronix? NanoVibronix saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,700 shares, a decrease of 63.0% from the March 15th total of 7,300 shares. Based on an average daily trading volume, of 97,400 shares, the short-interest ratio is presently 0.0 days. Currently, 0.1% of the shares of the company are short sold. View NanoVibronix's Short Interest. When is NanoVibronix's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NAOV earnings forecast. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) released its earnings results on Monday, April, 8th. The company reported ($0.39) earnings per share (EPS) for the quarter. The company had revenue of $1.18 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 123.23% and a negative net margin of 162.55%. When did NanoVibronix's stock split? NanoVibronix shares split on the morning of Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly minted shares were payable to shareholders after the market closes on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NAOV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
